Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$42.71
+1.6%
$46.56
$41.38
▼
$105.65
$60.93B0.5820.33 million shs13.04 million shs
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
$82.26
+1.7%
$88.81
$79.27
▼
$186.81
$75.09B0.94184,592 shs204,437 shs
Luxottica Group SpA stock logo
LUXTY
Luxottica Group
$55.80
+0.4%
$55.80
$49.83
▼
$69.03
$27.07B0.2714,259 shs2,900 shs
Stryker Corporation stock logo
SYK
Stryker
$277.27
+0.1%
$304.41
$267.00
▼
$392.55
$106.24B0.782.85 million shs1.48 million shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Boston Scientific Corporation stock logo
BSX
Boston Scientific
+1.74%+0.24%-5.17%-4.40%-55.85%
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
+1.72%+2.00%-4.70%-15.88%-49.36%
Luxottica Group SpA stock logo
LUXTY
Luxottica Group
0.00%0.00%0.00%0.00%0.00%
Stryker Corporation stock logo
SYK
Stryker
+0.26%+0.45%+0.46%-15.94%-26.13%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$42.71
+1.6%
$46.56
$41.38
▼
$105.65
$60.93B0.5820.33 million shs13.04 million shs
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
$82.26
+1.7%
$88.81
$79.27
▼
$186.81
$75.09B0.94184,592 shs204,437 shs
Luxottica Group SpA stock logo
LUXTY
Luxottica Group
$55.80
+0.4%
$55.80
$49.83
▼
$69.03
$27.07B0.2714,259 shs2,900 shs
Stryker Corporation stock logo
SYK
Stryker
$277.27
+0.1%
$304.41
$267.00
▼
$392.55
$106.24B0.782.85 million shs1.48 million shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Boston Scientific Corporation stock logo
BSX
Boston Scientific
+1.74%+0.24%-5.17%-4.40%-55.85%
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
+1.72%+2.00%-4.70%-15.88%-49.36%
Luxottica Group SpA stock logo
LUXTY
Luxottica Group
0.00%0.00%0.00%0.00%0.00%
Stryker Corporation stock logo
SYK
Stryker
+0.26%+0.45%+0.46%-15.94%-26.13%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Boston Scientific Corporation stock logo
BSX
Boston Scientific
2.67
Moderate Buy$66.3155.25% Upside
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
2.63
Moderate BuyN/AN/A
Luxottica Group SpA stock logo
LUXTY
Luxottica Group
0.00
N/AN/AN/A
Stryker Corporation stock logo
SYK
Stryker
2.79
Moderate Buy$370.6833.69% Upside

Current Analyst Ratings Breakdown

Latest LUXTY, SYK, ESLOY, and BSX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/7/2026
Stryker Corporation stock logo
SYK
Stryker
Reiterated RatingMarket Perform
10/7/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
UpgradeHold
10/7/2026
Stryker Corporation stock logo
SYK
Stryker
UpgradeStrong-Buy
10/6/2026
Stryker Corporation stock logo
SYK
Stryker
Initiated CoverageOverweight$375.00
10/6/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Initiated CoverageOverweight ➝ Equal Weight$48.00
10/6/2026
Stryker Corporation stock logo
SYK
Stryker
Lower Price TargetHold$340.00 ➝ $310.00
10/5/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Lower Price TargetNeutral$50.00 ➝ $48.00
10/3/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Reiterated RatingOutperform$54.00
10/2/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Reiterated RatingSell (D+)
9/30/2026
Stryker Corporation stock logo
SYK
Stryker
Lower Price TargetBuy$360.00 ➝ $330.00
9/23/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Lower Price TargetEqual Weight$50.00 ➝ $48.00
(Data available from 10/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$20.07B3.08$4.10 per share10.42$16.49 per share2.59
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
$32.23B2.37$7.79 per share10.56$48.22 per share1.71
Luxottica Group SpA stock logo
LUXTY
Luxottica Group
$10.34B2.62$3.57 per share15.62$13.74 per share4.06
Stryker Corporation stock logo
SYK
Stryker
$25.12B4.23$16.91 per share16.40$58.63 per share4.73
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$2.90B$2.4717.2912.711.0117.50%19.28%10.89%10/28/2026 (Estimated)
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
$2.62BN/AN/A18.572.33N/AN/AN/AN/A
Luxottica Group SpA stock logo
LUXTY
Luxottica Group
$1.17B$2.2924.37N/AN/AN/AN/AN/AN/A
Stryker Corporation stock logo
SYK
Stryker
$3.25B$9.6528.7316.671.7514.43%23.63%11.39%10/29/2026 (Estimated)

Latest LUXTY, SYK, ESLOY, and BSX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/29/2026Q3 2026
Stryker Corporation stock logo
SYK
Stryker
$3.56N/AN/AN/A$6.63 billionN/A
10/28/2026Q3 2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$0.7530N/AN/AN/A$5.13 billionN/A
7/30/2026Q2 2026
Stryker Corporation stock logo
SYK
Stryker
$3.49$3.69+$0.20$3.30$6.58 billion$6.59 billion
7/29/2026Q2 2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$0.83$0.86+$0.03$0.61$5.38 billion$5.44 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Boston Scientific Corporation stock logo
BSX
Boston Scientific
N/AN/AN/AN/AN/A
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
$1.672.03%N/AN/AN/A
Luxottica Group SpA stock logo
LUXTY
Luxottica Group
$0.911.63%N/A39.74%N/A
Stryker Corporation stock logo
SYK
Stryker
$3.521.27%+7.58%36.48%32 Years

Latest LUXTY, SYK, ESLOY, and BSX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/4/2026
Stryker Corporation stock logo
SYK
Stryker
quarterly$0.881.28%9/30/20269/30/202610/30/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.43
1.24
0.74
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
N/AN/AN/A
Luxottica Group SpA stock logo
LUXTY
Luxottica Group
0.19
1.18
0.88
Stryker Corporation stock logo
SYK
Stryker
0.59
2.16
1.33

Institutional Ownership

CompanyInstitutional Ownership
Boston Scientific Corporation stock logo
BSX
Boston Scientific
89.07%
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
0.01%
Luxottica Group SpA stock logo
LUXTY
Luxottica Group
0.09%
Stryker Corporation stock logo
SYK
Stryker
77.09%

Insider Ownership

CompanyInsider Ownership
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.34%
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
N/A
Luxottica Group SpA stock logo
LUXTY
Luxottica Group
75.00%
Stryker Corporation stock logo
SYK
Stryker
4.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Boston Scientific Corporation stock logo
BSX
Boston Scientific
59,0001.45 billion1.44 billionOptionable
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
203,791928.49 millionN/ANot Optionable
Luxottica Group SpA stock logo
LUXTY
Luxottica Group
82,282485.06 millionN/ANot Optionable
Stryker Corporation stock logo
SYK
Stryker
56,000383.57 million365.93 millionOptionable

Recent News About These Companies

Stryker Corporation (NYSE:SYK) Stock Has Average Price Target of $370.68
Stryker (SYK) Stock Could Be Cheap After Its 26% Slide
Stryker (NYSE:SYK) Upgraded to "Strong-Buy" at Barclays
Stryker (NYSE:SYK) Stock Rating Upgraded by Barclays
Stryker (SYK) Dropped, What Is Behind The Fresh Attention?
Stryker will have a new CEO next year

New MarketBeat Followers Over Time

Media Sentiment Over Time

Boston Scientific stock logo

Boston Scientific NYSE:BSX

$42.71 +0.67 (+1.59%)
Closing price 10/9/2026 03:59 PM Eastern
Extended Trading
$42.56 -0.14 (-0.34%)
As of 10/9/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

EssilorLuxottica stock logo

EssilorLuxottica OTCMKTS:ESLOY

$82.26 +1.39 (+1.72%)
As of 10/9/2026 03:59 PM Eastern

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. It operates through Professional Solutions and Direct to Consumer segments. The company offers lens under the Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir, eyexpert, iWear, Humanware, and Optifog brands. It also provides finishing equipment, vision performance screening, eye examination and refractions, fitting parameter measurements, and small tools and consumables under the Essilor Instruments brand; high-tech equipment for optical surfacing, polishing, measuring, coating, and finishing, as well as consumables, tools, and services under the Satisloh brand. In addition, the company provides eyewear products under the Ray-Ban, Oakley, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Alain Mikli, Costa, Bliz, Native, Luxottica, Sferoflex, Bolon, Molsion, DbyD, and Unofficial and Seen, as well as other Licensed brands. In addition, the company designs, develops, markets, and maintains lens edging and mounting instruments for opticians and prescription laboratories; and optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions. It wholesales its products to independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry; and sells directly to consumers through the network of brick and mortar retail network and its online channels. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.

Luxottica Group stock logo

Luxottica Group OTCMKTS:LUXTY

$55.80 +0.20 (+0.36%)
As of 03/22/2019

Luxottica Group S.p.A., together with its subsidiaries, provides fashion, luxury, sports, and performance eyewear worldwide. It operates through two segments, Manufacturing and Wholesale Distribution, and Retail Distribution. The Manufacturing and Wholesale Distribution segment engages in the design, manufacture, distribution, and marketing of proprietary and designer lines of prescription frames and sunglasses. This segment offers its products under proprietary brands, such as Ray-Ban, Oakley, Persol, Oliver Peoples, Alain Mikli, Arnette, and Vogue Eyewear; and licensed brands, including Giorgio Armani, Emporio Armani, Armani Exchange, Brooks Brothers, Burberry, Bulgari, Chanel, Coach, Dolce&Gabbana, DKNY, Michael Kors, Paul Smith Spectacles, Prada, Miu Miu, Ralph Lauren, Polo Ralph Lauren, Ralph, Starck Eyes, Tiffany & Co, Tory Burch, Valentino, Versace, and Ferrari. The Retail Distribution segment operates prescription eyewear stores primarily under its retail brands, including LensCrafters, Sunglass Hut, Pearle Vision, OPSM, Laubman & Pank, GMO, David Clulow, Salmoiraghi & Viganò, Ray-Ban, Oakley and Vault, Oliver Peoples, Alain Mikli, Ilori Optical, and Optical Shop of Aspen; and licensed brands, such as Sears Optical and Target Optical. As of December 31, 2017, it operated approximately 9,000 stores. The company was founded in 1961 and is headquartered in Milan, Italy. As of October 1, 2018, Luxottica Group S.p.A. operates as a subsidiary of EssilorLuxottica.

Stryker stock logo

Stryker NYSE:SYK

$277.27 +0.30 (+0.11%)
Closing price 10/9/2026 03:59 PM Eastern
Extended Trading
$277.82 +0.55 (+0.20%)
As of 10/9/2026 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.